9 results
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
of obstruction, symptom ... corticosteroid; LABA ... long-acting β2-agonist; LAMA ... #LABA #LAMA #SABA ... #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... perceived level of symptoms ... LAMA: long-acting ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager ... Renal Syndromes ... WORKUP & DIAGNOSIS Labs ... or serologies + symptoms ... diagnosis #management #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Diagnosis: • Labs ... Imaging: CXR- pulmonary ... Diagnosis: >3 symptoms
The Stages of Syphilis 

Primary Syphilis 
- The chancre lesion is the hallmark of primary syphilis.
include penis and labia ... Without treatment ... called condyloma lata ... and nephrotic syndrome ... exposure to or symptoms
Summary of Oncologic Emergencies

Neutropenic fever:
- Fever + ANC < 500 → start cefepime ± vancomycin (if
rapid-turnover” SCLC - Lab ... Ca - q8 h TLS labs ... rise from last lab ... → no immediate treatment ... renal failure, pulmonary
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... acute coronary syndrome ... icu #clinical #pharmacology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... respiratory distress syndrome ... gradually with symptoms ... Improvement in symptoms ... Labs: • Nonspecific
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic